Regulatory News

Appointment of Ernst & Young LLP

RNS Number : 3624Q
Darktrace PLC
20 February 2023

Darktrace plc

20 February 2023



Appointment of Ernst & Young LLP

Darktrace plc ("Darktrace") (DARK.L), a global leader in cyber security AI, announces that further to its statement on 1 February 2023, it has appointed Ernst & Young LLP ("E&Y") to provide an additional independent third-party review of its key financial processes and controls as outlined in that statement. E&Y will report to the Chair of the Darktrace Audit & Risk Committee, Paul Harrison.

The Board and management are confident that Darktrace's independently audited public company financial statements fairly represent Darktrace's financial position and results. The Board and management stand firmly behind the statement made on 1 February 2023 and they believe it appropriate to demonstrate that by commissioning an independent review.


Gordon Hurst, Chair of the Board said:

"The Board believes fully in the robustness of Darktrace's financial processes and controls. As a sign of that confidence, we have commissioned this independent third-party review by E&Y.  We look forward to the outcome of this review."


Darktrace will report its half year results for the six months ending 31 December 2022 on Wednesday 8 March 2023. Darktrace does not expect to be in a position to provide an update on the review at that time. Darktrace will report the key findings of the E&Y review once it is complete. Darktrace reiterates the guidance given in its trading update of 11 January 2023.




Luk Janssens - Head of Investor Relations, Darktrace

+44 7811 027918

[email protected]


Powerscourt (Public Relations adviser to Darktrace)

Peter Ogden/Victoria Palmer-Moore/Elly Williamson

+44 (0) 20 7250 1446

[email protected]




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.